<unk>  (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption.<unk>  was invented and developed by GelTex Pharmaceuticals.<unk>  is marketed by Sanofi under the brand names Renagel<unk>  hydrochloride) and Renvela<unk>  carbonate).
Sevelamer
Etofibrate
Tirofiban
Ganirelix
Rosuvastatin
Cetrorelix
Lovastatin
Fenofibrate